Hyperglycemia management in the hospital setting.
暂无分享,去创建一个
[1] Bruce W Bode,et al. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. , 2005, Diabetes care.
[2] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[3] K. Jablonski,et al. Unrecognized Diabetes Among Hospitalized Patients , 1998, Diabetes Care.
[4] Kingston H. Tseng,et al. Standards of Medical Care in Diabetes–2006 , 2006, Diabetes Care.
[5] P. Brunetti,et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. , 2000, Diabetes.
[6] James D Dziura,et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.
[7] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[8] G. Peterson. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir , 2006, Current medical research and opinion.
[9] H. Mcdonald,et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. , 2005, JAMA.
[10] S. Mudaliar,et al. Insulin therapy in type 2 diabetes. , 2001, Endocrinology and metabolism clinics of North America.
[11] M. Feinglos,et al. Drug-induced hyperglycemia. , 2001, JAMA.
[12] F. Brancati,et al. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. , 1997, Archives of internal medicine.
[13] J. Plank,et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. , 2005, Diabetes care.
[14] P. Dumo,et al. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] Bruce W Bode,et al. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[16] L. Heinemann,et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. , 2004, Diabetes.
[17] Ace Ada Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control , 2006, Diabetes Care.
[18] Irl B Hirsch,et al. Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.
[19] Silvio E. Inzucchi,et al. Management of Hyperglycemia in the Hospital Setting , 2006 .